Has Robert Heros, MD received payments from drug or device companies?

Yes. Drug and device makers reported $298,797 in general payments to Robert Heros, MD across 573 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Robert Heros, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Robert Heros, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Robert Heros, MD

Pain Medicine · Tualatin, ORNPI 1588655708

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (39.0%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. MML US, Inc. accounts for 85.8% of it on its own, with 14 other manufacturers making up the rest. Among pain medicine clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$298,797in general payments, 2019–2025

Across 573 payments — averaging $521.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

MML US, Inc.$256K
Boston Scientific$14K
Saluda Medical Americas, Inc.$13K
Abbott$9K
Biotronik Inc.$3K
Biotronik NRO, Inc.$1K
plus $2K from 9 others

$1,511,723in research payments, 2019–2025

Across 270 payments — averaging $5598.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Abbott$790K
MML US, Inc.$689K
Saluda Medical Americas, Inc.$26K
Nevro Corp.$7K

What the payments were for

Consulting fees$105,75035%
Speaking & faculty fees$116,65939%
Travel & lodging$55,78819%
Food & beverage$20,6007%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
MML US, Inc.	298	$256,222
Boston Scientific	51	$14,248
Saluda Medical Americas, Inc.	77	$12,775
Abbott	98	$8,508
Biotronik Inc.	1	$3,300
Biotronik NRO, Inc.	13	$1,281
Relievant Medsystems, Inc.	3	$908
Painteq LLC	6	$475
Nevro Corp.	9	$391
Axonics, Inc.	8	$338
Nalu Medical, Inc.	4	$161
Corelink, LLC	1	$78
SPR Therapeutics, Inc	1	$47
Medtronic	2	$42
Globus Medical	1	$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ReActiv8$250,705
Evoke$6,704
WAVEWRITER ALPHA$4,703
Evoke SCS$3,926
SPECTRA WAVEWRITER$3,585
Proclaim IPG$2,550
GENERAL PAIN MANAGEMENT$2,301
PROCLAIM$2,116
GENERAL - THERAPIES$1,944
Intracept$1,749
SUPERION$720
Prospera$717
Proclaim Family of SCS IPGs$586
Neuromodulation-Research Only$426
PAINTEQ$371
BIOTRONIK$311
Senza Spinal Cord Stimulation System$249
S-Series SCS Leads$140
Nalu Neurostimulation System$107
Axonics$103

How this compares

$298,797 in reported general payments places this provider in the 95th percentile of 57 pain medicine providers in Oregon.

See all pain medicine providers in Oregon →

Medicare billing

Part B allowed, 2024

$129,996

Medicare patients

301

Services billed

1,600

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Gabapentin	23	$444
Oxycodone Hcl	43	$202
Meloxicam	26	$120
Tizanidine Hcl	16	$99
Cephalexin	12	$88
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	12	$70
Lorazepam	19	$36
Tramadol Hcl	15	$30

Paid to pharmacies, not to this prescriber.

Other pain medicine in Tualatin

Vishal KhemlaniTualatin$338K
Jason AndersonTualatin$12K
Jerry LinTualatin$888
Joseph SavinoMedford$95K
Kimberly MauerPortland$59K
Stuart RosenblumPortland$31K
Andrew OhPortland$30K
Shawn SillsMedford$28K
Adrian AnthonyGresham$28K
Adam KempEugene$28K

See the full list for Oregon →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →